NO994995L - FremgangsmÕte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasøytiske blandinger inneholdende slike forbindelser - Google Patents
FremgangsmÕte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasøytiske blandinger inneholdende slike forbindelserInfo
- Publication number
- NO994995L NO994995L NO994995A NO994995A NO994995L NO 994995 L NO994995 L NO 994995L NO 994995 A NO994995 A NO 994995A NO 994995 A NO994995 A NO 994995A NO 994995 L NO994995 L NO 994995L
- Authority
- NO
- Norway
- Prior art keywords
- compound
- compounds
- activity
- determining
- pde
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/173,375 US6200771B1 (en) | 1998-10-15 | 1998-10-15 | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
| US09/366,003 US6130053A (en) | 1999-08-03 | 1999-08-03 | Method for selecting compounds for inhibition of neoplastic lesions |
| US09/414,628 US20020009764A1 (en) | 1999-10-08 | 1999-10-08 | Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994995D0 NO994995D0 (no) | 1999-10-14 |
| NO994995L true NO994995L (no) | 2000-04-17 |
Family
ID=27390268
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994995A NO994995L (no) | 1998-10-15 | 1999-10-14 | FremgangsmÕte for identifisering av forbindelser for inhibering av neoplastiske lesjoner og farmasøytiske blandinger inneholdende slike forbindelser |
| NO20062682A NO20062682L (no) | 1998-10-15 | 2006-06-09 | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20062682A NO20062682L (no) | 1998-10-15 | 2006-06-09 | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner |
Country Status (13)
| Country | Link |
|---|---|
| EP (2) | EP0997145B1 (no) |
| JP (1) | JP2000186047A (no) |
| CN (1) | CN100389829C (no) |
| AT (1) | ATE214920T1 (no) |
| AU (1) | AU770308B2 (no) |
| CA (1) | CA2284853A1 (no) |
| DE (1) | DE69901082T2 (no) |
| DK (1) | DK0997145T3 (no) |
| ES (1) | ES2174573T3 (no) |
| IL (1) | IL132366A0 (no) |
| NO (2) | NO994995L (no) |
| TR (1) | TR199902578A3 (no) |
| TW (1) | TWI239837B (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000033067A1 (en) * | 1998-11-25 | 2000-06-08 | Cell Pathways, Inc. | Method for diagnosing neoplasia |
| US6569638B1 (en) * | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
| RU2267489C2 (ru) * | 2000-08-21 | 2006-01-10 | Астразенека Аб | Производные хиназолина, способ их получения и фармацевтическая композиция |
| AU2003276220A1 (en) * | 2002-11-13 | 2004-06-03 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 2a (pde2a) |
| EP1670444B1 (en) | 2003-10-03 | 2011-04-27 | Veijlen N.V. | Use of indoleacetic acid derivatives which increase the serum igf-1 level for the preparation of a therapeutical composition for treatment of various diseases |
| JPWO2005054181A1 (ja) * | 2003-12-01 | 2007-12-06 | 株式会社リバース・プロテオミクス研究所 | 抗癌剤の新規標的タンパク質および対応する新規抗癌剤（スプナール） |
| JP5219135B2 (ja) * | 2008-07-25 | 2013-06-26 | 独立行政法人産業技術総合研究所 | 炎症性疾患モデル動物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69202721T2 (de) * | 1991-03-08 | 1995-10-12 | Fgn Inc | Substituierte Indenylverbindungen. |
| US5776962A (en) * | 1994-08-03 | 1998-07-07 | Cell Pathways, Inc. | Lactone compounds for treating patient with precancerous lesions |
| US5696159A (en) * | 1994-08-03 | 1997-12-09 | Cell Pathways, Inc. | Lactone compounds for treating patients with precancerous lesions |
| US5998477A (en) * | 1996-06-13 | 1999-12-07 | Cell Pathways Inc. | Substituted methoxy benzylidene indenyl-acetic and propionic acids for treating patients with precancerous lesions |
| US6063818A (en) * | 1996-06-13 | 2000-05-16 | Cell Pathways Inc. | Substituted benzylidene indenyl formamides, acetamides and propionamides |
| ES2245465T3 (es) * | 1996-09-18 | 2006-01-01 | Applied Genetics Incorporated Dermatics | Dioles de compuestos de norborneno y norbornano para el tratamiento de trastornos de la pigmentacion, enfermedades neurodegenerativas o enfermedades proliferativas de la piel. |
| CA2238283C (en) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions |
| US5922595A (en) * | 1997-12-09 | 1999-07-13 | Incyte Pharmaceuticals, Inc. | Cyclic GMP phosphodiesterase |
| AU752072B2 (en) * | 1997-12-12 | 2002-09-05 | Osi Pharmaceuticals, Inc. | N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
-
1999
- 1999-10-13 IL IL13236699A patent/IL132366A0/xx not_active IP Right Cessation
- 1999-10-14 EP EP99308129A patent/EP0997145B1/en not_active Expired - Lifetime
- 1999-10-14 AU AU54010/99A patent/AU770308B2/en not_active Ceased
- 1999-10-14 DK DK99308129T patent/DK0997145T3/da active
- 1999-10-14 NO NO994995A patent/NO994995L/no not_active Application Discontinuation
- 1999-10-14 EP EP01119687A patent/EP1161943A3/en not_active Withdrawn
- 1999-10-14 DE DE69901082T patent/DE69901082T2/de not_active Expired - Fee Related
- 1999-10-14 CA CA002284853A patent/CA2284853A1/en not_active Abandoned
- 1999-10-14 ES ES99308129T patent/ES2174573T3/es not_active Expired - Lifetime
- 1999-10-14 TW TW088117817A patent/TWI239837B/zh active
- 1999-10-14 AT AT99308129T patent/ATE214920T1/de not_active IP Right Cessation
- 1999-10-15 JP JP11330364A patent/JP2000186047A/ja active Pending
- 1999-10-15 CN CNB991218183A patent/CN100389829C/zh not_active Expired - Fee Related
- 1999-10-15 TR TR1999/02578A patent/TR199902578A3/tr unknown
-
2006
- 2006-06-09 NO NO20062682A patent/NO20062682L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE214920T1 (de) | 2002-04-15 |
| DE69901082D1 (de) | 2002-05-02 |
| CN1255379A (zh) | 2000-06-07 |
| EP1161943A3 (en) | 2003-12-10 |
| TWI239837B (en) | 2005-09-21 |
| CN100389829C (zh) | 2008-05-28 |
| EP1161943A2 (en) | 2001-12-12 |
| JP2000186047A (ja) | 2000-07-04 |
| EP0997145B1 (en) | 2002-03-27 |
| TR199902578A2 (xx) | 2000-06-21 |
| DE69901082T2 (de) | 2002-08-29 |
| IL132366A0 (en) | 2001-03-19 |
| DK0997145T3 (da) | 2002-07-29 |
| EP0997145A1 (en) | 2000-05-03 |
| AU770308B2 (en) | 2004-02-19 |
| NO994995D0 (no) | 1999-10-14 |
| CA2284853A1 (en) | 2000-04-15 |
| TR199902578A3 (tr) | 2000-06-21 |
| NO20062682L (no) | 2000-04-17 |
| AU5401099A (en) | 2000-04-20 |
| ES2174573T3 (es) | 2002-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062682L (no) | Farmasoytiske blandinger inneholdende forbindelser for inhibering av neoplastiske lesjoner | |
| ATE307119T1 (de) | Bicyclische protein-farnesyl-transferase inhibitoren | |
| BG106020A (en) | Inhibitors of impdh enzyme | |
| TR199802136T2 (xx) | �MPDH enzimi inhibit�rleri olarak �re t�revleri. | |
| NO965524L (no) | Tri-substituerte fenylderivater anvendelige som PDE IV inhibitorer | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| UA83243C2 (ru) | Соединения, которые ингибируют натриезависимый переносчик глюкозы | |
| NO996578L (no) | Urokinase-inhibitorer | |
| YU76401A (sh) | 1-amino triazolo(4,3-a)hinazolin-5-oni i/ili - 5-tioni koji inhibiraju fosfodiesteraze iv | |
| NO20003018D0 (no) | Triazinangiogenese-inhibitorer | |
| BR0211118A (pt) | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal | |
| CA2238283A1 (en) | Method for identifying compounds for inhibition of neoplastic lesions, pharmaceutical compositions from such compounds and uses of such compounds and compositions for treating neoplastic lesions | |
| DE69911935D1 (de) | Granulatimide-derivate zur behandlung von krebs | |
| MXPA03011466A (es) | Macrociclos utiles en tratamiento de enfermedades de alzheimer. | |
| ATE326964T1 (de) | Aminosäurederivate zur behandlung der alzheimer- krankheit | |
| MA27257A1 (fr) | Composes utiles pour le traitement du charbon et l'inhibition du gene letal | |
| CY2225B1 (en) | Organic compounds | |
| NO308829B1 (no) | Anvendelse av forbindelsen finasterid for fremstilling av et preparat for behandling av kronisk prostatitt hos menn | |
| MXPA03011399A (es) | Metodos para tratar la enfermedad de alzheimer. | |
| BR0307266A (pt) | Compostos que inibem a atividade do fator xa | |
| SI1077694T1 (en) | Aryl nitrone therapeutics for the treatment of inflammatory bowel disease | |
| ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. | |
| UY27524A1 (es) | Epta-, octa-y nonapéptidos con actividad antingiogénica | |
| ES2114476A1 (es) | Nuevas penicilinas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |